|Posted on 12/10/2015 3:26:00 AM.|
A pharmaceutical company out of Baton Rouge has created a therapeutic vaccine for prostate cancer. Phase one of the therapy vaccine, ProscaVax, developed by OncBioMune Pharmaceuticals Inc, has been approved by the FDA. CEO Jonathan Head says there is a huge need for this product and so far in trials it’s been a success with very little side effects.
|OncBioMune, ProscaVax, Jonathan Head, prostate cancer, vaccine, FDA|
|Posted on 8/29/2015 7:41:00 AM.|
LSU offensive coordinator Cam Cameron says he's been diagnosed with prostate cancer, but he's fine and his health is good. Cameron says he's already had it treated.
"Given a clean bill of health, pathology reports are 100%, locked, loaded and ready to go," Cameron said.
|Cam Cameron, prostate cancer, LSU Tigers|